Optimizing adjuvant treatment in HR+/HER2- early breast cancer

Optimizing HER2-Positive Breast Cancer Therapy: Balancing Efficacy and ToxicityПодробнее

Optimizing Early Breast Cancer Outcomes in the Community Setting: An Expert Review of Emerging Th...Подробнее

WATCH NOW: Optimizing Early Breast Cancer Outcomes in the Community SettingПодробнее

Optimizing adjuvant endocrine therapy for early Breast CancerПодробнее

Optimizing treatment in patients with early-stage HER2-positive breast cancerПодробнее

Lightning Updates | 2023 Best of Breast ConferenceПодробнее

Dr. Charles Perou | Distinguished Lectureship in Breast Cancer Research | SABCS 2022Подробнее

Assessment of short preoperative endocrine therapy in the ADAPT and ADAPTcycle trialsПодробнее

2022 KU Post San Antonio Review | Early-Stage Hormone + Breast Cancer: Optimizing Systemic TherapyПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. SchwartzbergПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Hope S. RugoПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Bagegni & Dr. GradisharПодробнее

Dr. Meisel on Optimizing Genomic Assays in Early-Stage HR-Positive, HER2-Negative Breast CancerПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Kaklamani and Dr. O’ReganПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Meisel & Dr. SolimanПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Traina & Dr. CareyПодробнее

Optimizing Therapy in HER2+ Disease with Dr. Reshma MahtaniПодробнее

Dr. Muss on Optimizing Adjuvant Treatment for Older Breast Cancer PatientsПодробнее